These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32601165)

  • 1. Preclinical Evaluation of Acylhydrazone SB-AF-1002 as a Novel Broad-Spectrum Antifungal Agent.
    Lazzarini C; Haranahalli K; McCarthy JB; Mallamo J; Ojima I; Del Poeta M
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.
    Lazzarini C; Haranahalli K; Rieger R; Ananthula HK; Desai PB; Ashbaugh A; Linke MJ; Cushion MT; Ruzsicska B; Haley J; Ojima I; Del Poeta M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids.
    Mor V; Rella A; Farnoud AM; Singh A; Munshi M; Bryan A; Naseem S; Konopka JB; Ojima I; Bullesbach E; Ashbaugh A; Linke MJ; Cushion M; Collins M; Ananthula HK; Sallans L; Desai PB; Wiederhold NP; Fothergill AW; Kirkpatrick WR; Patterson T; Wong LH; Sinha S; Giaever G; Nislow C; Flaherty P; Pan X; Cesar GV; de Melo Tavares P; Frases S; Miranda K; Rodrigues ML; Luberto C; Nimrichter L; Del Poeta M
    mBio; 2015 Jun; 6(3):e00647. PubMed ID: 26106079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nascent Nanoformulations as an Insight into the Limitations of the Conventional Systemic Antifungal Therapies.
    Kaur M; Shivgotra R; Bhardwaj N; Saini S; Thakur S; Jain SK
    Curr Drug Targets; 2023; 24(2):171-190. PubMed ID: 36443967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
    Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH; Walsh TJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
    Groll AH; Walsh TJ
    Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel triazole antifungal agents.
    Hoffman HL; Ernst EJ; Klepser ME
    Expert Opin Investig Drugs; 2000 Mar; 9(3):593-605. PubMed ID: 11060698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Zinc-Attenuating Compounds as Potent Broad-Spectrum Antifungal Agents with
    Cohrt KAO; Marín L; Kjellerup L; Clausen JD; Dalby-Brown W; Calera JA; Winther AL
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Sterylglucosidase A to Treat Aspergillus fumigatus Infections.
    Pereira de Sa N; Jayanetti K; Rendina D; Clement T; Soares Brauer V; Mota Fernandes C; Ojima I; Airola MV; Del Poeta M
    mBio; 2023 Apr; 14(2):e0033923. PubMed ID: 36877042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antifungal activities of miltefosine analogs.
    Ravu RR; Chen YL; Jacob MR; Pan X; Agarwal AK; Khan SI; Heitman J; Clark AM; Li XC
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4828-31. PubMed ID: 23891181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostics and therapy for invasive fungal infections in an intensive care unit].
    Koch S; Haefner H; Huenger F; Haase G; Wildberger J; Lemmen SW
    Anaesthesist; 2005 Oct; 54(10):1047-64; quiz 1065-6. PubMed ID: 16211405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of micafungin in the antifungal armamentarium.
    Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
    Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD; Perfect JR
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.